What are the side effects of oral glucosamine tablets and chondroitin sulfate?

Side Effects of Glucosamine and Chondroitin Sulfate

Glucosamine and chondroitin sulfate are safe and associated with few side effects, with adverse events being mild, infrequent, and evenly distributed compared to placebo. 1

Safety Profile Based on Guidelines

The EULAR 2003 guidelines explicitly state that these products are "safe and associated with few side effects" based on meta-analysis of trials up to 1999 1. The 2008 NICE guidelines, while not recommending their use due to lack of efficacy evidence, do not cite safety concerns as a reason for this recommendation 2.

Specific Side Effects to Counsel Patients About

Hypersensitivity Reactions (Most Important)

• Allergic reactions are the primary concern, ranging from mild to severe:
  • Mild reactions: pruritus, urticaria, generalized erythema, lip/facial edema 3, 4
  • Moderate reactions: dyspnea, nausea, vomiting, abdominal pain, chest tightness, dizziness 3
  • Severe reactions: hypotension, confusion, collapse, gait disturbance, somnolence 3
• In Australian surveillance data (2000-2011), 71.85% of reported adverse reactions were hypersensitivity-related, with 16.3% classified as severe 3
• Delayed onset is possible: symptoms can develop within 3 hours but may progress over subsequent hours 4

Hepatotoxicity (Rare but Important)

• Elevation in aminotransferases has been reported in patients with chronic liver disease 5
• May present with or without concurrent skin rash 5
• Caution advised in patients with pre-existing liver disease - monitor liver function tests if these supplements are used 5

Gastrointestinal Effects

• Diarrhea is specifically mentioned with diacerein (a related compound) 6
• Nausea and abdominal pain reported in hypersensitivity reactions 3

Clinical Context from Efficacy Studies

The GAIT trial (largest study, N=1583) found adverse events were "mild, infrequent, and evenly distributed among the groups" including placebo 7. This reinforces that when side effects occur, they are not substantially more frequent than background rates.

Key Clinical Pitfalls

1. Shellfish allergy connection: Many glucosamine products are derived from shellfish. While the evidence doesn't definitively establish causation, clear labeling is needed for patients with known shellfish allergy or atopy 3

2. Drug interactions appear minimal: Recent investigation of cytochrome P450 interactions showed no significant inhibitory effects on seven CYP isozymes, suggesting low potential for drug-drug interactions 8. However, isolated case reports of glucosamine interactions exist, warranting general caution 8

3. Don't dismiss patient reports: The delayed nature of some allergic reactions means patients may not immediately connect symptoms to supplement initiation 4

Bottom Line for Patient Counseling

Tell patients these supplements have a favorable safety profile with minimal side effects in most users. However, they should stop immediately and seek medical attention if they develop rash, facial swelling, difficulty breathing, or unexplained symptoms after starting these products. Patients with shellfish allergies or pre-existing liver disease should discuss use with their physician before starting.